Company page
Briacell Therapeutics Corp
Briacell Therapeutics Corp is a public company listed on the Canadian market under the ticker BCT. The company has a market capitalization of approximately CAD 25.3 million. Briacell focuses on developing innovative immunotherapies for cancer treatment.
- Ticker
- BCT:TSX
- Asset type
- Stock
- Market cap
- $25.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD